Certain populations are at increased risk for methotrexate toxicity. Patients with renal impairment may experience elevated drug levels due to reduced excretion. Elderly patients often have decreased renal function and are more susceptible to toxic effects. Genetic variations in enzymes involved in methotrexate metabolism, such as MTHFR, can also influence toxicity risk.
